MAIORANA, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 37.954
EU - Europa 21.653
AS - Asia 14.797
SA - Sud America 2.299
Continente sconosciuto - Info sul continente non disponibili 582
AF - Africa 389
OC - Oceania 62
Totale 77.736
Nazione #
US - Stati Uniti d'America 37.072
IT - Italia 9.564
GB - Regno Unito 4.550
SG - Singapore 4.506
CN - Cina 3.744
BR - Brasile 1.728
HK - Hong Kong 1.655
VN - Vietnam 1.528
SE - Svezia 1.472
DE - Germania 1.422
FI - Finlandia 744
UA - Ucraina 723
FR - Francia 707
RU - Federazione Russa 706
BD - Bangladesh 689
TR - Turchia 611
CA - Canada 488
IN - India 454
IE - Irlanda 402
KR - Corea 353
NL - Olanda 285
BG - Bulgaria 282
ID - Indonesia 234
MX - Messico 182
AR - Argentina 165
JP - Giappone 153
PL - Polonia 129
IQ - Iraq 123
CH - Svizzera 98
PK - Pakistan 98
ZA - Sudafrica 93
AE - Emirati Arabi Uniti 92
MY - Malesia 91
CO - Colombia 88
BE - Belgio 83
ES - Italia 80
EC - Ecuador 79
EG - Egitto 68
CL - Cile 67
PH - Filippine 60
AU - Australia 57
IR - Iran 57
LT - Lituania 56
VE - Venezuela 53
AT - Austria 52
CR - Costa Rica 42
SA - Arabia Saudita 42
UZ - Uzbekistan 40
PY - Paraguay 39
MA - Marocco 38
CZ - Repubblica Ceca 35
RO - Romania 35
TN - Tunisia 34
NG - Nigeria 33
DZ - Algeria 32
PE - Perù 32
KE - Kenya 31
AL - Albania 30
JM - Giamaica 29
IL - Israele 28
JO - Giordania 27
PT - Portogallo 27
RS - Serbia 27
AZ - Azerbaigian 24
TH - Thailandia 24
TW - Taiwan 24
GR - Grecia 23
BO - Bolivia 22
UY - Uruguay 22
EU - Europa 19
NP - Nepal 18
DK - Danimarca 17
KZ - Kazakistan 17
HN - Honduras 16
OM - Oman 16
DO - Repubblica Dominicana 15
GT - Guatemala 15
SV - El Salvador 15
BY - Bielorussia 14
ET - Etiopia 14
HR - Croazia 14
BB - Barbados 13
NI - Nicaragua 13
BH - Bahrain 12
PA - Panama 12
HU - Ungheria 11
LB - Libano 11
BZ - Belize 10
PR - Porto Rico 10
SK - Slovacchia (Repubblica Slovacca) 10
GE - Georgia 9
PS - Palestinian Territory 9
TT - Trinidad e Tobago 9
MD - Moldavia 8
NO - Norvegia 8
KG - Kirghizistan 7
LK - Sri Lanka 7
MK - Macedonia 7
EE - Estonia 6
LU - Lussemburgo 6
Totale 77.051
Città #
Ashburn 3.997
Southend 3.141
Santa Clara 3.056
Fairfield 2.981
Singapore 2.930
Chandler 1.801
San Jose 1.622
Woodbridge 1.607
Hong Kong 1.606
Houston 1.413
Jacksonville 1.267
Seattle 1.159
Dearborn 1.086
Wilmington 1.047
Ann Arbor 1.025
Cambridge 1.007
Hefei 995
Council Bluffs 922
Nyköping 878
Milan 829
Chicago 772
Los Angeles 754
Beijing 742
London 680
New York 641
Rome 592
Helsinki 486
Ho Chi Minh City 467
Modena 451
Dublin 386
The Dalles 382
Hanoi 339
Salt Lake City 335
Izmir 334
San Diego 328
Seoul 318
Munich 299
Princeton 293
Sofia 266
Dallas 235
Buffalo 232
Lauterbourg 221
Eugene 210
Bologna 205
Moscow 191
São Paulo 188
Naples 187
Shanghai 186
Columbus 158
Florence 157
Tampa 157
Jakarta 144
Elk Grove Village 140
Phoenix 128
Frankfurt am Main 120
Toronto 114
Boardman 101
Orem 101
Redwood City 98
Palermo 95
Tokyo 95
Turin 93
Bremen 83
Bari 82
Des Moines 81
Fremont 81
Atlanta 80
Da Nang 79
Warsaw 78
Sterling 77
Brooklyn 74
Lancaster 73
Haiphong 70
Ottawa 68
Mumbai 65
Padova 63
Turku 62
Mexico City 59
Brussels 58
Chennai 58
New Delhi 58
Denver 57
Genoa 56
Cagliari 54
Grafing 54
Catania 53
Miami 53
Guangzhou 52
Norwalk 51
Falls Church 50
Boston 49
Dong Ket 49
Parma 48
Philadelphia 48
Rio de Janeiro 48
Montreal 46
Verona 46
Stockholm 45
Baghdad 44
Detroit 44
Totale 49.086
Nome #
Angiomixoma aggressivo della pelvi e del perineo. Presentazione di un caso clinico e revisione della letteratura 6.217
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 1.179
Type 3 hypersensitivity in COVID-19 vasculitis 992
Spiradenoma eccrino al dorso della mano: presentazione di un caso 683
Post-mortem diagnosis of encephalitis in a 75-year-old man associated with human herpesvirus-6 variant A 609
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 529
Ex-vivo Fluorescence Confocal Microscopy: The First Application For Real-Time Pathologic Examination of Prostatic Tissue 519
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 486
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 481
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 468
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 460
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 452
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 441
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 441
A case of primary cardiac angiosarcoma: extensive right atrial wall reconstruction with autologous pericardium. 438
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 438
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour 430
Cutaneous metastases as the first manifestation of pleural malignant mesothelioma. 429
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 424
Granular cell tumor of the appendix: a new case and review of the literature 423
The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients 420
Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. 417
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 417
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 410
INI1 immunohistochemical expression in glioblastoma: correlation with MGMT gene promoter methylation status and patient survival 410
Well-differentiated papillary mesothelioma of the epididymis in a man with recurrent haematospermia. 409
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 405
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 404
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 400
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 397
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 395
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 395
Sentinel lymph node biopsy in clear cell sarcoma. 394
Localized pleural metastatic adenosarcoma of the uterine cervix mimicking a malignant solitary fibrous tumour: CD10 has no value in differential diagnosis 386
Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells 382
Malacoplachia del testicolo. Descrizione di un caso. 380
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 378
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 377
Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas 376
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 375
Placental transmogrification of the lung: Clinicopathologic, immunohistochemical and molecular study of two cases, with particular emphasis on the interstitial clear cells 375
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 374
"Is this case of a very rare disease work-related?" a review of reported cases of pacinian neuroma 373
Acquired immunodeficiency similar to Gulf War illness in a dead former serviceman 373
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 372
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 369
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 362
Ex vivo fluorescence confocal microscopy: prostatic and periprostatic tissues atlas and evaluation of the learning curve 362
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 361
Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients 361
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 359
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 356
Survivin modulates squamous cell carcinoma-derived stem-like cell proliferation, viability and tumor formation in vivo 355
Surgical margins in head and neck squamous cell carcinoma: what is 'close'? 355
Psoriasis vs allergic contact dermatitis in palms and soles: A quantitative histologic and immunohistochemical study 352
Real-time assessment of surgical margins during radical prostatectomy: a novel approach that uses fluorescence confocal microscopy for the evaluation of peri-prostatic soft tissue 351
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFR alpha, PDGFR beta, and met in large-cell neuroendocrine carcinoma of the lung 350
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 345
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 342
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 340
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 337
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 336
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 333
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 333
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 330
Isolation and Characterization of Squamous Cell Carcinoma-Derived Stem-like Cells: Role in Tumor Formation 328
BRAF V600E mutation in washing liquid of thyroid fine-needle aspiration: a surprising tool in cytological benign nodules. 328
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 327
Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry 324
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 322
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 320
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 320
Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pilori interventions: results from a population-based study on extranodal marginal zone lymphomas 318
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 318
Can prostatitis to be a confounding parameter in prostatic proteomic profile designation? 317
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 317
Prediction of Distant Recurrence-Free Survival in Resectable Lung Adenocarcinoma. 313
Adenolipoma della trachea. Descrizione di un caso trattato mediante resezione-anastomosi tracheale. 313
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence 312
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 309
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 307
Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumor invasion 305
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 305
Pre-miR146a expression in follicular carcinomas of the thyroid 301
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 301
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 299
An unusual case of signet ring cell adenocarcinoma of the prostate 298
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 298
A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients 297
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 293
Pre-miR146a expression profiling of follicular thyroid carcinoma 291
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 290
Osteoid Osteoma of the Atlas in a Boy: Clinical and Imaging Features-A Case Report and Review of the Literature 290
A new case of juxtaglomerular cell tumor in a patient with bilateral adrenalectomy because of MEN2A 288
Expression of ALDH and SOX-2 in Pulmonary Sclerosing Pnemocytoma (PSP) of the Lung: Is There a Meaning Behind? 288
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 287
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 286
Expression and clinicopathological role of miR146a in thyroid follicular carcinoma. 285
Changes in survivin subcellular localization correlates with different stages of differentiation in normal and cancerous skin 283
Clinical impact and prognostic role of KRAS/BRAF/PIK3CA mutations in stage I colorectal cancer 282
Totale 43.982
Categoria #
all - tutte 279.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 279.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.655 0 0 0 500 223 405 289 333 645 541 1.019 700
2022/20236.327 711 638 454 564 647 758 227 519 997 135 322 355
2023/20244.857 198 275 241 450 951 515 435 492 141 281 381 497
2024/202511.736 471 206 278 866 2.169 1.764 941 737 1.296 643 989 1.376
2025/202622.125 1.306 794 1.721 2.999 4.368 1.385 2.221 1.037 1.990 1.729 1.521 1.054
2026/20274.228 671 1.258 1.615 684 0 0 0 0 0 0 0 0
Totale 77.736